Mr. Thompson has served as our Chief Commercial Officer since January 2011. Previously, he was Vice President of Marketing for Pfizer’s Specialty Care Business Unit where he was directly responsible for the U.S. commercial strategy for products with over $1.5 billion in annual U.S. sales including Zyvox®, Tygacil®, Vfend®, Eraxis®, Rapammune® and Relistor®. Prior to his 7 years at Pfizer, Mr. Thompson served in positions of increasing responsibility for 12 years at Merck where he most notably worked on the commercial planning and marketing activities for the company’s anti-infectives Primaxin®, Mefoxin® and Cancidas® as well as major cardiovascular brands including Vytorin®, Zetia® and Zocor®. Mr. Thompson earned a Bachelors degree from McMaster University and an MBA from the University of Notre Dame.